AI Discovery Award
AI Discovery by Nebius is an annual award for startups that are leveraging AI to revolutionize drug discovery, biotechnology, genomics and healthtech.
Our mission is to spotlight new technologies, foster collaboration between startups and potential investors and propel the next generation of breakthroughs in healthcare.
Apply till 30.04.2025 and compete for $100 000 in cloud credits.
Award categories
AI in Drug Discovery
Transforming how we discover and develop new treatments.
AI in Biotech
Innovations at the intersection of biology and technology.
Genomics & Multiomics
Advancements in genetic and molecular analysis.
HealthTech
Revolutionizing healthcare delivery and patient outcomes.
Preliminary timeline
30 April 2025
Applications submission deadline.
11 May 2025
Announcement of the finalists
12–30 May 2025
Final consideration.
June 2025
Official awards ceremony.
Winners receive
.jpg?cache-buster=2025-01-16T15:40:25.692Z)
.svg?cache-buster=2025-01-16T15:49:30.267Z){kind=icon}
Who can apply
Each participant should have a legal entity, a functioning website, product MVP and GTM strategy.
Startups developing AI products in fields such as drug discovery, biotech, genomics and healthtech
Bootstrapped, self-funded and funded startups at any stage from pre-seed up to and including Series C.
Qualification Criteria
AI powered
The product uses advanced AI/ML technologies for model training or inference and manages HPC workloads effectively.
Technological innovation
The product or service advances the industry by introducing new capabilities or significant improvements.
Functionality and advantages
The product offers superior or unique functionality, providing a competitive edge and enhancing business processes.
Performance and efficiency
The product delivers measurable results with clear metrics or case studies, improving customer performance effectively.
Global impact
The product addresses unique needs and solves specific problems, creating meaningful value on a global scale.
Market potential and business sustainability
The product demonstrates strong market demand and long-term potential, ensuring growth opportunities and a sustainable competitive advantage.
Judging committee
To join the judging committee, please reach out to dpol@nebius.com.
.jpg?cache-buster=2025-01-16T16:12:38.513Z)
Dr. Ilya Burkov
PhD, MSc, BEng. Global Life Sciences and Healthcare Lead at Nebius with former clinical experience at Addenbrooke’s Hospital and cloud expertise from AWS. Passionate about AI in Life Sciences.
Cedric Steenbeke
A healthcare tech expert with 15+ years of experience, leads NVIDIA’s Healthcare & Life Sciences startup ecosystem in EMEA. Previously at Microsoft, he shaped healthcare data platforms and AI adoption, driving digital health innovation.
Pavel Sinitcyn, Ph.D
Assistant Professor in AI Technology for Life, and Biomolecular Mass Spectrometry groups at Utrecht University.
Dr. Andrew Buchanan
Principal Scientist at AstraZeneca with 25 years in commercial R&D. An expert in biologics targeting (ADC & RC), AI/ML innovation, and mentoring. A Fellow of the Royal Society of Chemistry (2020), co-author of 40+ papers and patents.
Lev Kogon
PhD in Health Economics. Biotech and pharma leader with 15+ years of global experience in strategy, business development, and licensing. VP at Nykode Therapeutics. Worked for Bayer, Daiichi Sankyo and GSK.
Artemy Shumskiy
Senior Associate at LongeVC with profound academic and industry experience in oncology and aging biotechnology.
Apply now
FAQ
Applications submission deadline is on April 30, 2025.